Literature DB >> 16328112

Improvement of cervico-trunco-brachial segmental dystonia with topiramate.

Spiridon Papapetropoulos, Carlos Singer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16328112     DOI： 10.1007/s00415-005-0029-3

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  14 in total

1.  Control of Tourette's syndrome with topiramate.

Authors:  F S Abuzzahab; V L Brown
Journal:  Am J Psychiatry       Date:  2001-06       Impact factor: 18.112

2.  Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series.

Authors:  K N Roy Chengappa; J Levine; D Rathore; H Parepally; R Atzert
Journal:  Eur Psychiatry       Date:  2001-04       Impact factor: 5.361

3.  Acute myopia and angle-closure glaucoma induced by topiramate.

Authors:  Matthias Boentert; Herbert Aretz; Peter Ludemann
Journal:  Neurology       Date:  2003-11-11       Impact factor: 9.910

4.  Topiramate reduces levodopa-induced dyskinesia in the MPTP-lesioned marmoset model of Parkinson's disease.

Authors:  Monty A Silverdale; S L Nicholson; A R Crossman; J M Brotchie
Journal:  Mov Disord       Date:  2005-04       Impact factor: 10.338

5.  Effects of topiramate in patients with cerebellar tremor.

Authors:  GianPietro Sechi; Virgilio Agnetti; Franca M I Sulas; GianFranco Sau; Davide Corda; Maria G Pitzolu; Giulio Rosati
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-09       Impact factor: 5.067

Review 6.  Focus on topiramate in neuropathic pain.

Authors:  Jean G Dib
Journal:  Curr Med Res Opin       Date:  2004-12       Impact factor: 2.580

Review 7.  An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action.

Authors:  R P Shank; J F Gardocki; A J Streeter; B E Maryanoff
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

8.  Spinal myoclonus responsive to topiramate.

Authors:  Antonio Siniscalchi; Franco Mancuso; Emilio Russo; Guido Ferreri Ibbadu; Giovambattista De Sarro
Journal:  Mov Disord       Date:  2004-11       Impact factor: 10.338

9.  Vascular hemichorea/hemiballism and topiramate.

Authors:  Emilia Mabel Gatto; Claudia Uribe Roca; Gabriela Raina; Marcelo Gorja; Silvia Folgar; Federico E Micheli
Journal:  Mov Disord       Date:  2004-07       Impact factor: 10.338

10.  Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.

Authors:  Avinash Prasad; Ruben I Kuzniecky; Robert C Knowlton; Tim E Welty; Roy C Martin; M Mendez; Raymond E Faught
Journal:  Arch Neurol       Date:  2003-08
View more
  5 in total

Review 1.  Dystonia and leveraging oral pharmacotherapy.

Authors:  Michelle Ann C Sy; Hubert H Fernandez
Journal:  J Neural Transm (Vienna)       Date:  2021-04-20       Impact factor: 3.575

2.  Movement disorders in patients taking anticonvulsants.

Authors:  C Zadikoff; R P Munhoz; A N Asante; N Politzer; R Wennberg; P Carlen; A Lang
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-29       Impact factor: 10.154

3.  Treatment of generalized dystonia.

Authors:  Naomi Lubarr; Susan Bressman
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

Review 4.  Antiseizure Drugs and Movement Disorders.

Authors:  Michel Sáenz-Farret; Marina A J Tijssen; Dawn Eliashiv; Robert S Fisher; Kapil Sethi; Alfonso Fasano
Journal:  CNS Drugs       Date:  2022-07-21       Impact factor: 6.497

5.  Clinical utility of adjunctive retigabine in partial onset seizures in adults.

Authors:  Konrad Rejdak; Jarogniew J Luszczki; Barbara Błaszczyk; Roman Chwedorowicz; Stanislaw J Czuczwar
Journal:  Ther Clin Risk Manag       Date:  2012-01-20       Impact factor: 2.423
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.